-
1
المؤلفون: Zhuoer Xie, Julie T Wu, Huili Zhu, Deborah B. Doroshow, Yu Shyr, Thorvardur R. Halfdanarson, Jessica Hawley, Sanjay Mishra, Lidia Schapira, Leslie A. Fecher, Sanjay Goel, Samuel M. Rubinstein, Petros Grivas, Pamela C Egan, Solange Peters, Sumit A. Shah, Gary K. Schwartz, Michael A. Thompson, Jonathan T Arcobello, Chih-Yuan Hsu, Christopher R. Friese, Dimitrios Farmakiotis, Corrie A. Painter, Matthew D. Galsky, Nicole M. Kuderer, Nathan A. Pennell, Ziad Bakouny, Sanjay G. Revankar, Brian I. Rini, Albert C. Yeh, Donna R. Rivera, Jeremy L. Warner, Dimpy P. Shah, Brendan J Lee, Ali Raza Khaki, Adam J. Olszewski, Matthew Puc, Orestis A. Panagiotou, Gary H. Lyman, Christopher Lemmon, Balazs Halmos, Andrew Schmidt, Toni K. Choueiri, Gilberto Lopes, Shilpa Gupta
المساهمون: COVID-19 and Cancer Consortium
المصدر: Cancer Discovery
Cancer discovery, vol. 10, no. 10, pp. 1514-1527مصطلحات موضوعية: Male, 0301 basic medicine, Logistic regression, Severity of Illness Index, 0302 clinical medicine, Risk Factors, Neoplasms, Hospital Mortality, Research Articles, Alanine, Age Factors, Middle Aged, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Coronavirus Infections, Hydroxychloroquine, Cohort study, medicine.drug, medicine.medical_specialty, Clinical Decision-Making, Pneumonia, Viral, Betacoronavirus, 03 medical and health sciences, Sex Factors, Pharmacotherapy, Internal medicine, Statistical significance, Severity of illness, medicine, Humans, Healthcare Disparities, Glucocorticoids, Pandemics, Aged, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Alanine/analogs & derivatives, Alanine/therapeutic use, Betacoronavirus/pathogenicity, Coronavirus Infections/complications, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Drug Therapy, Combination/methods, Drug Therapy, Combination/statistics & numerical data, Drug Utilization/statistics & numerical data, Follow-Up Studies, Glucocorticoids/therapeutic use, Healthcare Disparities/statistics & numerical data, Hydroxychloroquine/therapeutic use, Neoplasms/complications, Neoplasms/mortality, Pneumonia, Viral/complications, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Pneumonia, Viral/mortality, United States/epidemiology, SARS-CoV-2, business.industry, COVID-19, Cancer, medicine.disease, Adenosine Monophosphate, Drug Utilization, United States, COVID-19 Drug Treatment, 030104 developmental biology, Observational study, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19be86f094f92aafe7221786c1b2cd6
https://doi.org/10.1158/2159-8290.cd-20-0941 -
2
المؤلفون: Jonathan T, Arcobello, Sanjay G, Revankar
المصدر: Seminars in Respiratory and Critical Care Medicine. 41:131-140
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Immunocompromised Host, Phaeohyphomycosis, Antifungal Agents, Fungi, Humans, Critical Care and Intensive Care Medicine
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe5bac92635aab77c558e3874592e9b
https://doi.org/10.1055/s-0039-3400957